Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

18 Nov 2021 Evaluate

Cadila Healthcare has informed that it enclosed a press release dated November 18, 2021, titled ‘Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..